Weighted Average Number of Shares Outstanding, Diluted of Oncocyte Corp from Q1 2022 to Q3 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Oncocyte Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q1 2022 to Q3 2025.
- Oncocyte Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 32M shares, a 134% increase year-over-year.
- Oncocyte Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 13.1M shares, a 70.8% increase from 2023.
- Oncocyte Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 7.65M shares, a 38.1% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)